Nautilus Biotechnology, Inc. income statement NAUT

It recorded a net loss of $59.0 million. Diluted earnings per share were -$0.47.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Sep 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Research and development
39
-11.9%
41
-18.6%
50
+6.8%
47
+25.4%
38
+28.3%
29
Selling, general and administrative
—
26
-17.0%
31
+7.3%
29
+11.4%
26
+22.7%
21
Income tax
0
0
0
0
0
0
Net income
-59
+6.7%
-59
+16.6%
-71
-11.2%
-64
-9.9%
-58
-15.1%
-50
Basic EPS
-0.46
+7.3%
-0.47
+16.1%
-0.56
-9.8%
-0.51
-10.9%
-0.46
+23.3%
-0.60
Diluted EPS
-0.46
+7.3%
-0.47
+16.1%
-0.56
-9.8%
-0.51
-10.9%
-0.46
+23.3%
-0.60
Weighted average shares, basic
127
+0.6%
126
+0.7%
125
+0.4%
125
+0.3%
125
+47.5%
84
Weighted average shares, diluted
127
+0.6%
126
+0.7%
125
+0.4%
125
+0.3%
125
+47.5%
84
Other measures
Depreciation and amortization
1
-31.7%
2
-15.0%
2
+8.2%
2
+51.9%
1
+19.4%
1
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
NAUT (Nasdaq)
Fiscal year ends
December 31
Headquarters
Seattle, WA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1808805
Former names
ARYA Sciences Acquisition Corp III (until Jun 8, 2021)

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.